S

B

SMITH , B. Douglas

Last name: SMITH

First name: B. Douglas

October 17, 2022 (v1)

Publication

Metadata-only

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

Heuser, Michael Smith, B. Douglas Fiedler, Walter

This analysis from the phase II BRIGHT AML 1003 trial reports the long-term efficacy and safety of glasdegib + low-dose cytarabine (LDAC) in patients with acute myeloid leukemia ineligible for intensive chemotherapy. The multicenter, open-label study randomized (2:1) patients to receive glasdegib + LDAC (de novo, n = 38; secondary acute myeloid...

Uploaded on: December 4, 2022